+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Intravenous (IV) Solutions - Global Market Trajectory & Analytics

  • ID: 5303481
  • Report
  • February 2022
  • Region: Global
  • 423 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Amanta Healthcare
  • Anhui Medipharm Co., LTD.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen Ag
  • Baxter International Inc.
  • Fresenius Kabi AG

Global Intravenous (IV) Solutions Market to Reach US$15 Billion by the Year 2026


Intravenous solutions are nutrients such as amino acids, vitamins & minerals, carbohydrates, and parenteral lipid emulsion among others, which are delivered intravenously to the patient. Intravenous feeding of nutrients involves administration of nutritional supplements to the body through vein. Intravenous therapy is generally administered to patients with a non-functional gastrointestinal tract or those unable to consume nutrition through the oral route. An aging population, rising prevalence of chronic diseases, and the need to address nutritional needs of such patients are fueling growth in IV solutions market. Since the geriatric population is more likely to experience deficiency of various essential nutrients, intravenous therapy is often used to provide the necessary nutrition in this population. Growing number of preterm births is another factor driving market growth. Increasing number of pediatric GI disorders is also likely to foster demand for infant IV nutrition going forward. Another factor fueling growth in the IV solutions market is the growing threat of malnutrition particularly in low- and mid-income nations. The market is anticipated to generate increased revenue due to the IV infusions` rising positive clinical trials, which are propelling the vitamin C IV therapy`s adoption to treat cancer.

Amid the COVID-19 crisis, the global market for Intravenous (IV) Solutions estimated at US$10.1 Billion in the year 2020, is projected to reach a revised size of US$15 Billion by 2026, growing at a CAGR of 6.8% over the analysis period. Total Parenteral Nutrition, one of the segments analyzed in the report, is projected to grow at a 7.1% CAGR to reach US$11 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Peripheral Parenteral Nutrition segment is readjusted to a revised 6% CAGR for the next 7-year period. This segment currently accounts for a 32.8% share of the global Intravenous (IV) Solutions market. Total parenteral nutrition (TPN) is an approach that involves intravenous infusion of carefully balanced blend of minerals and vitamins. The treatment is administered in life-threatening scenarios such as intestinal failure, where a patient is unable to digest and absorb essential nutrients including minerals and vitamins required for survival. Furthermore, the TPN market is estimated to develop rapidly because of the increased significance in treating inflammatory bowel diseases such as Crohn`s and ulcerative colitis disease. Peripheral Parenteral Nutrition (PPN) is a short-term therapy that is provided only until enteral or central venous access is obtained or in the form of supplement to oral intake.



The U.S. Market is Estimated at $4.1 Billion in 2021, While China is Forecast to Reach $1.4 Billion by 2026


The Intravenous (IV) Solutions market in the U.S. is estimated at US$4.1 Billion in the year 2021. The country currently accounts for a 38.86% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$1.4 Billion in the year 2026 trailing a CAGR of 8.4% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.5% CAGR while Rest of European market (as defined in the study) will reach US$684.3 Million by the end of the analysis period. A growing elderly population with greater susceptibility to chronic illnesses is driving need for IV solutions in developed economies. Advent of novel IV solutions to meet the nutritional needs of pediatric patients, and growing awareness about the benefits of IV nutrition therapy for patients suffering from severe malnutrition are presenting favorable growth opportunities in developed economies. The high prevalence of malnourishment among children and high instances of malnutrition among expectant mothers, due to the large number of low- and mid-income nations in the regions, are driving demand for IV solutions. To deal with the issue, global organizations such as the UN and regional governments are undertaking aggressive awareness programs to reduce mortality rates, which is encouraging greater adoption of IV and PN solutions in healthcare settings.

Select Competitors (Total 67 Featured) -

  • Amanta Healthcare
  • Anhui Medipharm Co., LTD.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen Ag
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited.
  • Vifor Pharma Management Ltd.
Frequently Asked Questions about the Global Market for Intravenous (IV) Solutions

What is the estimated value of the Global Market for Intravenous (IV) Solutions?

The Global Market for Intravenous (IV) Solutions was estimated to be valued at $10.1 Billion in 2020.

What is the growth rate of the Global Market for Intravenous (IV) Solutions?

The growth rate of the Global Market for Intravenous (IV) Solutions is 6.8%, with an estimated value of $15.0 Billion by 2026.

What is the forecasted size of the Global Market for Intravenous (IV) Solutions?

The Global Market for Intravenous (IV) Solutions is estimated to be worth $15.0 Billion by 2026.

Who are the key companies in the Global Market for Intravenous (IV) Solutions?

Key companies in the Global Market for Intravenous (IV) Solutions include Amanta Healthcare, Anhui Medipharm Co., LTD., Axa Parenterals Ltd., B. Braun Melsungen Ag, Baxter International Inc., Fresenius Kabi AG, Grifols, S.A., ICU Medical, Inc. and Otsuka Pharmaceutical Co. Ltd..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amanta Healthcare
  • Anhui Medipharm Co., LTD.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen Ag
  • Baxter International Inc.
  • Fresenius Kabi AG

I. METHODOLOGY


II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Impact of COVID-19 Pandemic and Looming Global Recession
  • 2020: A Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021?
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Pandemic Affects Demand for Intravenous Solutions
  • Elective Surgeries Report Roller-Coaster Ride Amid COVID-19, Affecting Demand for IV Solutions
  • COVID-19 Induced YOY Decline in Heart Surgery Volumes in the US in 2020
  • COVID-19 Results in Colossal Backlog of Elective Surgeries & Extended Waiting Times
  • Intravenous (IV) Solutions – Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • An Introduction to Intravenous (IV) Solutions
  • Types of Intravenous Solutions
  • Global Market Prospects & Outlook
  • TPN Emerges as the Largest Segment in the IV Solutions Market
  • Single Dose Amino Acid Solutions: The Major Nutrient Type
  • Developed Economies Lead, Developing Regions to Propel Future Growth
  • Competition
  • World Brands
  • Recent Market Activity

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Growing Prevalence of Malnutrition in Hospitalized Patients to Fuel Need for IV Solutions
  • Daily Requirements for Adults (Male and Female) by Nutrient Type
  • Energy Requirements by Age and Gender
  • Rising Prevalence of Chronic Diseases and Resultant Need for Additional Nutrition Enhances Need to Administer IV Solutions
  • Rising Cancer Incidence and Need for Nutritional Support
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2020
  • Number of New Cancer Cases and Deaths (in Million) by Region for 2020
  • Alarming Rise in Diabetes Incidence Worldwide
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • World Diabetes Prevalence (2000-2045)
  • Global Prevalence of Diabetes: Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2019, 2030 and 2045
  • Global Diabetes Mellitus Population Breakdown by Geographic Region: 2019, 2030 and 2045
  • Unrelenting Threat of HIV/AIDS Infection
  • Global HIV Prevalence: Number of People Living with AIDs (in Thousands) by Region for 2020
  • Number of AIDS-Related Deaths (in Thousands) by Region for 2018
  • Nutritional Management of Patients with Neurological Diseases
  • Burden of Neurological Diseases: Deaths Per 100,000 Population due to Neurological Conditions in Select Countries
  • Concerns over Fluid Depletion from Body Due to GI & Diarrheal Diseases Necessitate IV Fluid Administration
  • Growing Numbers of Pre-term Births Drives Demand for IV Solutions
  • Top Countries Ranked by Most Number of Preterm Births
  • Countries with Highest Preterm Birth Rates: Number of Preterm Births Per 100 Live Births by Top Countries
  • Demand Rises for Home Intravenous Nutritional Therapies
  • Premixed IV Nutrition: A Step towards Safer Medication Practices
  • Premixed Formulations Present Efficient Delivery System
  • Iron Replacement Therapies: Potential for Growth
  • Growing Demand for Low-Cost Intravenous Nutrition Solutions
  • COVID-19 Outbreak: Combating Medication Errors in IV Infusion
  • Aging Global Demography and Resultant Rise in Need for Nutrition Management Augurs Well for the Market
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Increasing Healthcare Expenditure Creates Conducive Environment
  • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 & 2023
  • Challenges Confronting IV Solutions Market

4. GLOBAL MARKET PERSPECTIVE


III. MARKET ANALYSIS

UNITED STATES

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)

CANADA

JAPAN

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)

CHINA

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)

EUROPE

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)

FRANCE

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)

GERMANY

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)

ITALY

UNITED KINGDOM

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)

SPAIN


RUSSIA


REST OF EUROPE

ASIA-PACIFIC

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)

AUSTRALIA

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)

INDIA

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)

SOUTH KOREA


REST OF ASIA-PACIFIC

LATIN AMERICA

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)

ARGENTINA


BRAZIL


MEXICO


REST OF LATIN AMERICA

MIDDLE EAST

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)

IRAN


ISRAEL


SAUDI ARABIA


UNITED ARAB EMIRATES


REST OF MIDDLE EAST

AFRICA

  • Intravenous (IV) Solutions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)

IV. COMPETITION

  • Total Companies Profiled: 67
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Amanta Healthcare
  • Anhui Medipharm Co., LTD.
  • Axa Parenterals Ltd.
  • B. Braun Melsungen Ag
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Grifols, S.A.
  • ICU Medical, Inc.
  • JW Life Science
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Salius Pharma Private Limited.
  • Vifor Pharma Management Ltd.
Note: Product cover images may vary from those shown